Terragen Holdings Limited engages in the research, development, production, and sale of biological products for agriculture sectors in Australia and New Zealand.
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.29|
|52 Week High||AU$0.23|
|52 Week Low||AU$0.49|
|1 Month Change||-6.35%|
|3 Month Change||11.32%|
|1 Year Change||-34.44%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||47.50%|
Recent News & Updates
Terragen Holdings (ASX:TGH) Is In A Good Position To Deliver On Growth Plans
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
|TGH||AU Chemicals||AU Market|
Return vs Industry: TGH underperformed the Australian Chemicals industry which returned 11.3% over the past year.
Return vs Market: TGH underperformed the Australian Market which returned 20.2% over the past year.
Stable Share Price: TGH is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: TGH's weekly volatility (10%) has been stable over the past year.
About the Company
Terragen Holdings Limited engages in the research, development, production, and sale of biological products for agriculture sectors in Australia and New Zealand. It offers Great Land, a soil conditioner containing live and naturally occurring bacterial species from the Lactobacillus and Acetobacter genera; and Mylo, an animal feed supplement. The company was incorporated in 1996 and is based in Coolum Beach, Australia.
Terragen Holdings Fundamentals Summary
|TGH fundamental statistics|
Is TGH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|TGH income statement (TTM)|
|Cost of Revenue||AU$464.42k|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.032|
|Net Profit Margin||-167.02%|
How did TGH perform over the long term?See historical performance and comparison
Is Terragen Holdings undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate TGH's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate TGH's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: TGH is unprofitable, so we can't compare its PE Ratio to the Australian Chemicals industry average.
PE vs Market: TGH is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate TGH's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: TGH is overvalued based on its PB Ratio (4.4x) compared to the AU Chemicals industry average (4x).
How is Terragen Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Materials industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Terragen Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Terragen Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TGH is currently unprofitable.
Growing Profit Margin: TGH is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: TGH is unprofitable, and losses have increased over the past 5 years at a rate of 19.6% per year.
Accelerating Growth: Unable to compare TGH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TGH is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-61.8%).
Return on Equity
High ROE: TGH has a negative Return on Equity (-46.84%), as it is currently unprofitable.
How is Terragen Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: TGH's short term assets (A$13.3M) exceed its short term liabilities (A$1.4M).
Long Term Liabilities: TGH's short term assets (A$13.3M) exceed its long term liabilities (A$281.4K).
Debt to Equity History and Analysis
Debt Level: TGH is debt free.
Reducing Debt: TGH had no debt 5 years ago.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TGH has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: TGH has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 19.1% each year.
What is Terragen Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate TGH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate TGH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if TGH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TGH's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of TGH's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. James MacGregor Cooper, also known as Jim, has been the Chief Executive Officer, Managing Director and Executive Director at Terragen Holdings Limited since June 25, 2020. Mr. Cooper was previously a S...
CEO Compensation Analysis
Compensation vs Market: Jim's total compensation ($USD1.49M) is above average for companies of similar size in the Australian market ($USD302.72K).
Compensation vs Earnings: Jim's compensation has increased whilst the company is unprofitable.
Experienced Management: TGH's management team is not considered experienced ( 0.4 years average tenure), which suggests a new team.
Experienced Board: TGH's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.1%.
Terragen Holdings Limited's employee growth, exchange listings and data sources
- Name: Terragen Holdings Limited
- Ticker: TGH
- Exchange: ASX
- Founded: 1996
- Industry: Fertilizers and Agricultural Chemicals
- Sector: Materials
- Market Cap: AU$52.100m
- Shares outstanding: 192.96m
- Website: https://www.terragen.com.au
- Terragen Holdings Limited
- 39-41 Access Crescent
- Unit 6
- Coolum Beach
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/18 07:05|
|End of Day Share Price||2021/10/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.